Ocular Therapeutix, Inc

Add to watchlist
€12.3
Last updated:06/09/2021
0OT: F
Ocular Therapeutix, Inc

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device des… Show more

P/E ratio
-

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
-63.386M
-59.978M
+5.38%
-86.372M
-44.01%
-155.636M
-80.19%
Cashflow
Sum up money going in and out company
-50.473M
-49.227M
+2.47%
-77.578M
-57.59%
-53.554M
+30.97%
Total liabilities
All combined debts and obligations
29.284M
37.168M
+26.92%
82.37M
+121.62%
185.768M
+125.53%
Company profile
CEO
Mr. Antony Mattessich
Market capitalization
Small (0.93B)